Nanocarrier based approaches for targeting breast cancer stem cells
Breast cancer stem cells (BCSCs) are heterogeneous subpopulation of tumour initiating
cells within breast tumours. They are spared even after chemotherapy and responsible for …
cells within breast tumours. They are spared even after chemotherapy and responsible for …
Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells
In the present study, solid lipid nanoparticles (SLNs) have been formulated as a carrier
system for effective intracellular delivery of STAT3 inhibitor, niclosamide (Niclo) to triple …
system for effective intracellular delivery of STAT3 inhibitor, niclosamide (Niclo) to triple …
RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies
VT Siddhartha, SKSS Pindiprolu… - Artificial cells …, 2018 - Taylor & Francis
In the present study, we have demonstrated receptor for advanced glycation endproducts
(RAGE) as a target for delivery of drugs specifically to triple negative breast cancer cells. We …
(RAGE) as a target for delivery of drugs specifically to triple negative breast cancer cells. We …
DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer
In the present study, Death receptor-5 (DR5) antibody conjugated solid lipid nanoparticles
(DR5-DAPT-SLNs) has been formulated for effective intracellular of γ-secretase inhibitor, N …
(DR5-DAPT-SLNs) has been formulated for effective intracellular of γ-secretase inhibitor, N …